Nonantibiotic prophylaxis for recurrent urinary tract infections: A systematic review and meta-analysis of randomized controlled trials

Journal of Urology

Volumn 190, Issue 6, 2013, Pages 1981-1989

  Beerepoot, M A J ^a,b   Geerlings, S E ^a   Van Haarst, E P ^a   Mensing Van Charante, N ^a   Ter Riet, G ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Meta analysis; Prevention and control; Review; Urinary tract infections

Indexed keywords

'UROVAC'; ANGOCIN; ANTIINFECTIVE AGENT; CRANBERRY EXTRACT; ESTRADIOL; ESTRIOL; OM 89; PLACEBO; UNCLASSIFIED DRUG; URO VAXOM; UROVAC VAGINAL VACCINE;

ACUPUNCTURE; ANXIETY; BREAST CANCER; BREAST TENDERNESS; CEREBROVASCULAR ACCIDENT; CRANBERRY; CRANBERRY JUICE; DEPRESSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVENING DOSAGE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEADACHE; HOSPITAL ADMISSION; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INNATE IMMUNITY; INTENTION TO TREAT ANALYSIS; ISCHEMIC HEART DISEASE; LACTOBACILLUS RHAMNOSUS; LOW DRUG DOSE; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT INFECTION; REINFECTION; REVIEW; SAMPLE SIZE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; VAGINA BLEEDING; VAGINA DISCHARGE; VAGINA DISEASE; VENOUS THROMBOEMBOLISM;

EID: 84888643110     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.04.142     Document Type: Review

References (50)

1. Griebling TL: Urologic diseases in America project: trends in resource use for urinary tract infections in men. J Urol 2005;173:1288.
2. Stamm WE, McKevitt M, Roberts PL et al: Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991;13:77.
3. Albert X, Huertas I, Pereiró II et al: Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004;3: CD001209.
4. Beerepoot MA, Ter Riet G, Nys S et al: Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012;172:704.
5. Falagas ME, Betsi GI, Tokas T et al: Probiotics for prevention of recurrent urinary tract infections in women: a review of the evidence from microbiological and clinical studies. Drugs 2006;66:1253.
6. Jepson RG, Williams G and Craig JC: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2012;10: CD001321.
7. Lee BS, Bhuta T, Simpson JM et al: Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2012;10: CD003265.
8. Naber KG, Cho YH, Matsumoto T et al: Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents 2009;33:111.
9. Perrotta C, Aznar M, Mejia R et al: Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008;2: CD005131.
10. Moher D, Liberati A, Tetzlaff J et al: Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
11. Moher D, Jadad AR, Nichol G et al: Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62.
12. Higgins JP, Whitehead A and Simmonds M: Sequential methods for random-effects metaanalysis. Stat Med 2011;30:903.
13. Alraek T and Baerheim A: The effect of prophylactic acupuncture treatment in women with recurrent cystitis: kidney patients fare better. J Altern Complement Med 2003;9:651.
14. Uehling DT, Hopkins WJ, Beierle LM et al: Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis, suppl., 2001;183:S81.
15. Tammen H: Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol 1990;65:6.
16. Schulman CC, Corbusier A, Michiels H et al: Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 1993;150:917.
17. Magasi P, Pánovics J, Illés A et al: Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 1994;26:137.
18. Huber M, Krauter K, Winkelmann G et al: Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int J Immunopharmacol 2000;22:1103.
19. Bauer HW, Alloussi S, Egger G et al: A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol 2005;47:542.
20. Hopkins WJ, Elkahwaji J, Beierle L et al: Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. J Urol 2007;177:1349.
21. Uehling DT, Hopkins WJ, Balish E et al: Vaginal mucosal immunization for recurrent urinary tract infection: phase II clinical trial. J Urol 1997;157:2049.
22. Uehling DT, Hopkins WJ, Elkahwaji JE et al: Phase 2 clinical trial of a vaginal mucosal vaccine for urinary tract infections. J Urol 2003;170:867.
23. Raz R and Stamm WE: A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993;329:753.
24. Kirkengen AL, Andersen P, Gjersøe E et al: Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scand J Prim Health Care 1992;10:139.
25. Cardozo L, Benness C and Abbott D: Low dose oestrogen prophylaxis for recurrent urinary tract infections in elderly women. Br J Obstet Gynaecol 1998;105:403.
26. Anderson GL, Limacher M, Assaf AR et al: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701.
27. Hulley S, Grady D, Bush T et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605.
28. Eriksen B: A randomized, open, parallel-group study on the preventive effect of an estradiolreleasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999;180:1072.
29. Reid G and Bruce AW: Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis, suppl., 2001;183:S77.
30. Baerheim A, Larsen E and Digranes A: Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994;12:239.
31. Kontiokari T, Sundqvist K, Nuutinen M et al: Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322:1571.
32. Howell AB, Botto H, Combescure C et al: Dosage effect on uropathogenic Escherichia coli antiadhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. BMC Infect Dis 2010;10:94.
33. Stothers L: A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002;9:1558.
34. Albrecht U, Goos KH and Schneider B: A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections. Curr Med Res Opin 2007;23:2415.
35. Alraek T, Soedal LI, Fagerheim SU et al: Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health 2002;92:1609.
36. Aune A, Alraek T, Li Hua H et al: Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 1998;16:37.
37. Batterham AM and Hopkins WG: Emergence of large treatment effects from small trials. JAMA 2013;309:768.
38. Reid G, Bruce AW and Taylor M: Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32.
39. Reid G, Bruce AW and Taylor M: Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992;14:11.
40. Stapleton AE, Au-Yeung M, Hooton TM et al: Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 2011;52:1212.
41. Barbosa-Cesnik C, Brown MB, Buxton M et al: Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo-controlled trial. Clin Infect Dis 2011;52:23.
42. Sengupta KA, Alluri KV, Golakoti T et al: A randomized, double blind, controlled, dose dependent clinical trial to evaluate the efficacy of a proanthocyanidin standardized whole cranberry (Vaccinium macrocarpon) powder on infections of the urinary tract. Curr Bioact Compd 2011;7:39.
43. ClinicalTrials. Gov: Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs). Available at http://clinicaltrials. gov/show/NCT00100061. Accessed April 13, 2013.
44. Beerepoot MA, Ter Riet G, Nys S et al: Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011;171:1270.
45. McMurdo ME, Argo I, Phillips G et al: Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009;63:389.
46. Raz R, Colodner R, Rohana Y et al: Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003;36:1362.
47. Xu R, Wu Y and Hu Y: Prevention and treatment of recurrent urinary system infection with estrogen cream in postmenopausal women. Zhonghua Fu Chan Ke Za Zhi 2001;36:531.
48. EU Clinical Trials Register: Multicentre, doubleblind, placebo controlled randomised clinical study of URO-VAXOM® in female patients suffering from uncomplicated recurrent urinary tract infections. Available at www.clinicaltrialsregister. eu/ctr-search/trial/2007-004586-17/AT. Accessed November 25, 2012.
49. Abo-Zaid G, Sauerbrei W and Riley RD: Individual participant data meta-analysis of prognostic factor studies: state of the art? BMC Med Res Methodol 2012;12:56.
50. Klu YA, Williams JH, Phillips RD et al: Survival of Lactobacillus rhamnosus GG as influenced by storage conditions and product matrixes. J Food Sci 2012;77:M659.